Successful haploidentical BMT with post-transplant cyclophosphamide for refractory autoimmune pancytopenia after cord blood transplant in pediatric myelodysplastic syndrome

Bone Marrow Transplant. 2017 Apr;52(4):653-655. doi: 10.1038/bmt.2016.341. Epub 2017 Jan 9.

Authors

H Shima¹, K Isshiki¹, Y Yamada¹, F Yamazaki¹, T Takahashi¹, H Shimada¹

Affiliation

¹ Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.

PMID: 28067878
DOI: 10.1038/bmt.2016.341

No abstract available

Publication types

Case Reports

MeSH terms

Allografts
Autoimmune Diseases* / blood
Autoimmune Diseases* / etiology
Autoimmune Diseases* / pathology
Autoimmune Diseases* / therapy
Bone Marrow Transplantation*
Child, Preschool
Cord Blood Stem Cell Transplantation*
Cyclophosphamide / administration & dosage*
Female
Humans
Myelodysplastic Syndromes* / blood
Myelodysplastic Syndromes* / pathology
Myelodysplastic Syndromes* / therapy
Pancytopenia* / blood
Pancytopenia* / etiology
Pancytopenia* / pathology
Pancytopenia* / therapy

Substances

Cyclophosphamide